Alemtuzumab eliminates residual disease in 83% of patients w chronic lymphocytic leukemia. @hsplete reports. http://bit.ly/hHAsjN
10:32 AM - 6 Jan 2011
0 replies
1 retweet
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.